The neurofibromatosis 2 (NF2) tumor suppressor belongs to the Protein 4.1 family of molecules that link the actin cytoskeleton to cell surface glycoproteins. We have previously demonstrated that the NF2 protein, merlin, can suppress cell growth in vitro and in vivo as well as impair actin cytoskeletonassociated processes, such as cell spreading, attachment, and motility. Recently, we determined that expression of a second Protein 4.1 tumor suppressor, DAL-1, was lost in 60% of sporadic meningiomas, but not schwannomas. In this report, we demonstrate that DAL-1 suppresses cell proliferation in meningioma, but not schwannoma cells. Similar to merlin, DAL-1 interacts with other ERM proteins and ␤II-spectrin, but not the merlin interactor protein, SCHIP-1. In addition, we report the identification of the full-length DAL-1 tumor suppressor, termed KIAA0987. Collectively, these results suggest that the two Protein 4.1 meningioma tumor suppressors, merlin and DAL-1, may be functionally distinct proteins with different mechanisms of action.
INTRODUCTION
The Protein 4.1 family of molecules is composed of proteins that link the actin cytoskeleton to cell surface glycoproteins (Tsukita et al., 1994) . Two members of this protein family are hypothesized to function as tumor suppressors, the neurofibromatosis 2 (NF2) and the differentially expressed in adenocarcinoma of the lung (DAL-1) genes. The NF2 tumor suppressor was identified as the gene mutated in the NF2 familial cancer syndrome, in which affected individuals are susceptible to the development of schwannomas, meningiomas and ependymomas (Rouleau et al., 1993; Trofatter et al., 1993) . Mutations in the NF2 gene are found in NF2-associated tumors concomitant with loss of heterozygosity, supporting a two-hit mechanism for gene inactivation relevant to tumor formation (Sainz et al., 1994; Merel et al., 1995; Huynh et al., 1997; Stemmer-Rachamimov et al., 1997) . Moreover, NF2 inactivation is a common feature of sporadic schwannomas and meningiomas, suggesting that the NF2 gene plays a more general role in the control of Schwann and leptomeningeal cell growth (Deprez et al., 1994; Rubio et al., 1994; Ruttledge et al., 1994; Twist et al., 1994; Gutmann et al., 1997; Lee et al., 1997; StemmerRachamimov et al., 1997 StemmerRachamimov et al., , 1998 Ueki et al., 1999) . Merlin overexpression studies have demonstrated a significant reduction in cell proliferation in vitro as well as tumor growth in vivo (Sherman et al., 1997; Gutmann et al., 1998) .
The NF2 gene product, merlin (or schwannomin), is a member of the ezrin/radixin/moesin (ERM) family of Protein 4.1 molecules. Merlin is highly enriched in microvilli and filopodia as well as the ruffling edges of motile cells, similar to other ERM proteins (GonzalezAgosti et al., 1996; Scherer & Gutmann, 1996) . Whereas ERM proteins contain a conserved actin-binding motif in the carboxyl terminus of the protein, merlin lacks this domain and only weakly associates with the actin (Xu & Gutmann, 1998) . Regulated overexpression of merlin results in dramatic changes in the actin cytoskeleton and impairs cell attachment and motility
